Fingerprint
Dive into the research topics of 'Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab
Luai S. Al Rabadi, Madeline M. Cook, Andy J. Kaempf, Megan M. Saraceni, Michael A. Savin, Zahi I. Mitri
Research output: Contribution to journal › Article › peer-review
2
Scopus
citations